produits : 5 OVs teaser

AstraZeneca

Transgene and AstraZeneca have entered into a collaboration agreement under which Transgene designs five innovative oncolytic viruses based on the Invir.IO™ platform.

AstraZeneca can exercise an option on each of these candidates.